Two months earlier, Nature Health ran an editorial, not a study, an editorial, which in Nature-family journals is a specific genre of carefully argued professional opinion, making the case that the GLP-1 receptor agonist class deserves rigorous evaluation as a longevity therapeutic, not just a metabolic one
[DOI] [PMC free article] [PubMed] [Google Scholar] 216.Mikkelsen K., Apostolopoulos V
The outcome was the change in depressive symptom severity from baseline to end-of-treatment
Since there are obvious differences between rodent and human physiology, it cannot be ignored that this may have a significant impact on the efficacy and safety of (any) novel agents
Spatiotemporal changes in xylan-1/xyloglucan and xyloglucan xyloglucosyl transferase (XTH-Xet5) as a step-in of ultrastructural cell wall remodelling in potato Potato virus Y (PVY NTN ) hypersensitive and susceptible reaction